Compare Nvidia Corp (NVDA) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nvidia Corp vs GeneDx Holdings Corp — how do they compare? Nvidia Corp trades at $206.87 (market cap $4.92T), while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). The key difference: Nvidia Corp is far larger — about 2733.3× GeneDx Holdings Corp's market cap, and Nvidia Corp pays a 0.49% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| NVDA | WGS | |
|---|---|---|
Market Cap | $4.92T | $1.80B |
Sector | Technology | Technology |
52-Week High | $235.75 | $167.51 |
52-Week Low | $165.17 | $34.51 |
Enterprise Value | $4.86T | $1.80B |
Dividend Yield | 0.49% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Nvidia (NVDA) trades at $207.14, up 2.14% today, with a neutral technical signal and strong fundamental performance. Recent earnings consistently beat estimates, with Q1 2026 EPS of $1.87 exceeding the $1.76 forecast. Revenue surged to $130.50B in 2025, driving a net income margin of 62.97%. The stock faces resistance near $210, while support holds at $201.
Outlook remains positive due to AI-driven growth and robust profitability, but risks include peak AI spending concerns and competitive pressures. Analysts project a $325.86 price target, with 75% recommending Buy. Investors should weigh high valuation multiples against sustained earnings momentum.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nvidia Corp
NVIDIA Corporation designs, develops, and markets three dimensional (3D) graphics processors and related software. The Company offers products that provides interactive 3D graphics to the mainstream personal computer market.
Read more on NVDA →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
